title: Mutational analysis of EYA1, SIX1 and SIX5 genes and strategies for management of hearing loss in patients with BOR/BO syndrome.
abstract: BACKGROUND
  Branchio-oto-renal (BOR) or branchio-otic (BO) syndrome is one of the most common forms of autosomal dominant syndromic hearing loss. Mutations in EYA1, SIX1 and SIX5 genes have been associated with BOR syndrome. In this study, clinical and genetic analyses were performed in patients with BOR/BO syndrome focusing on auditory manifestations and rehabilitation.
  
  
  METHODS
  The audiologic manifestations were reviewed in 10 patients with BOR/BO syndrome. The operative findings and hearing outcome were analyzed in patients who underwent middle ear surgeries. The modality and outcome of auditory rehabilitation were evaluated. Genetic analysis was performed for EYA1, SIX1, and SIX5 genes.
  
  
  RESULTS
  All patients presented with mixed hearing loss. Five patients underwent middle ear surgeries without successful hearing gain. Cochlear implantation performed in two patients resulted in significant hearing improvement. Genetic analysis revealed four novel EYA1 mutations and a large deletion encompassing the EYA1 gene.
  
  
  CONCLUSIONS
  Auditory rehabilitation in BOR/BO syndrome should be individually tailored keeping in mind the high failure rate after middle ear surgeries. Successful outcome can be expected with cochlear implantations in patients with BOR/BO syndrome who cannot benefit from hearing aids. The novel EYA1 mutations may add to the genotypic and phenotypic spectrum of BOR syndrome in the East Asian population.
authors.affiliation: Department of Otorhinolaryngology, Kwandong University College of Medicine, Myongji Hospital, Goyang, South Korea.
authors.forename: Mee Hyun
authors.initials: MH
authors.lastname: Song
authors.forename: Tae-Jun
authors.initials: TJ
authors.lastname: Kwon
authors.forename: Hui Ram
authors.initials: HR
authors.lastname: Kim
authors.forename: Ju Hyun
authors.initials: JH
authors.lastname: Jeon
authors.forename: Jeong-In
authors.initials: JI
authors.lastname: Baek
authors.forename: Won-Sang
authors.initials: WS
authors.lastname: Lee
authors.forename: Un-Kyung
authors.initials: UK
authors.lastname: Kim
authors.forename: Jae Young
authors.initials: JY
authors.lastname: Choi
mesh_terms: D000293:Adolescent; D000328:Adult; D017398:Alternative Splicing; D001483:Base Sequence; D019280:Branchio-Oto-Renal Syndrome / Q000000981:diagnostic imaging / Q000235:genetics* / Q000503:physiopathology / Q000628:therapy; D002648:Child; D004252:DNA Mutational Analysis; D019468:Disease Management; D004432:Ear, Middle / Q000601:surgery; D005260:Female; D056726:Genetic Association Studies; D020022:Genetic Predisposition to Disease; D006367:HeLa Cells; D034381:Hearing Loss / Q000000981:diagnostic imaging / Q000235:genetics* / Q000503:physiopathology / Q000628:therapy; D018398:Homeodomain Proteins / Q000235:genetics*; D006801:Humans; D007223:Infant; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics* / Q000378:metabolism; D008969:Molecular Sequence Data; D009687:Nuclear Proteins / Q000235:genetics* / Q000378:metabolism; D017354:Point Mutation; D011110:Polymorphism, Genetic; D017027:Protein Tyrosine Phosphatases / Q000235:genetics* / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D011859:Radiography; D017384:Sequence Deletion; D013701:Temporal Bone / Q000002:abnormalities / Q000000981:diagnostic imaging; D055815:Young Adult
chemical_list: D018398:Homeodomain Proteins; D047908:Intracellular Signaling Peptides and Proteins; D009687:Nuclear Proteins; D012333:RNA, Messenger; C099236:SIX1 protein, human; C106687:SIX5 protein, human; C104381:EYA1 protein, human; D017027:Protein Tyrosine Phosphatases